Home > Insider Trading > Filing (0001209191-13-056152)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496268	Reva Medical Inc.	RVA:AX	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	330810505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1404477	Bain Robert Thomas	5751 Copley Drive San Diego CA 92111		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-06	7,500	$4.03	42,500	No	4	P	Indirect	Rob Thomas Superannuation Fund
Common Stock	Acquisiton	2013-12-10	2,500	$4.60	45,000	No	4	P	Indirect	Rob Thomas Superannuation Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Rob Thomas Superannuation Fund
No	4	P	Indirect	Rob Thomas Superannuation Fund

Footnotes

Represents the purchase of 75,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
The purchase was executed in the form of CDIs, trading on the Austrialian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $3.99 to $4.39. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Represents the purchase of 25,000 of the Company's Chess Depositary Interests (CDIs), trading on the Austrialian Securities Exchange.
This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $4.46 to $4.64. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.